BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22444165)

  • 1. Pneumococcal infections: association with asthma and COPD.
    Obert J; Burgel PR
    Med Mal Infect; 2012 May; 42(5):188-92. PubMed ID: 22444165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.
    Vila-Corcoles A; Ochoa-Gondar O
    Expert Rev Vaccines; 2012 Feb; 11(2):221-36. PubMed ID: 22309670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
    Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
    N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteremic pneumococcal pneumonia].
    Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
    An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonality of both bacteremic and nonbacteremic pneumonia coincides with viral lower respiratory tract infections in early childhood, in contrast to nonpneumonia invasive pneumococcal disease, in the pre-pneumococcal conjugate vaccine era.
    Ben-Shimol S; Greenberg D; Hazan G; Shemer-Avni Y; Givon-Lavi N; Dagan R
    Clin Infect Dis; 2015 May; 60(9):1384-7. PubMed ID: 25595749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric asthma and pneumococcal vaccination.
    Esposito S; Musio A; Principi N
    Vaccine; 2013 Oct; 31(44):5015-9. PubMed ID: 24021307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal disease manifestation in children before and after vaccination: what's new?
    Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
    Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.
    Adam D; Fehnle K
    Vaccine; 2008 Nov; 26(47):5944-51. PubMed ID: 18801402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.
    Lynch JP; Zhanel GG
    Curr Opin Pulm Med; 2010 May; 16(3):217-25. PubMed ID: 20375783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based impact of pneumococcal conjugate vaccine in young children.
    Poehling KA; Lafleur BJ; Szilagyi PG; Edwards KM; Mitchel E; Barth R; Schwartz B; Griffin MR
    Pediatrics; 2004 Sep; 114(3):755-61. PubMed ID: 15342850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
    Butler JR; McIntyre P; MacIntyre CR; Gilmour R; Howarth AL; Sander B
    Vaccine; 2004 Mar; 22(9-10):1138-49. PubMed ID: 15003641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.
    Fedson DS; Nicolas-Spony L; Klemets P; van der Linden M; Marques A; Salleras L; Samson SI
    Expert Rev Vaccines; 2011 Aug; 10(8):1143-67. PubMed ID: 21810065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease and risk of infection.
    Lange P
    Pneumonol Alergol Pol; 2009; 77(3):284-8. PubMed ID: 19591100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatricians' perspectives on the use of pneumococcal vaccine in healthy and asthmatic children.
    Karakaş T; Şahiner UM; Soyer OU; Civelek E; Cokugras H; Şekerel BE
    Allergol Immunopathol (Madr); 2010; 38(5):241-5. PubMed ID: 20656396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of pneumococcal infection in children in the developing world.
    Greenwood B
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):777-85. PubMed ID: 10365403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults.
    Rehm SJ; Farley MM; File TM; Hall WJ; Hopkins R; Levine OS; Nichol KL; Nuorti P; Zimmerman RK; Schaffner W
    Postgrad Med; 2009 Nov; 121(6):101-5. PubMed ID: 19940420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of pneumococcal disease through vaccination.
    Gentile A; Bazán V
    Vaccine; 2011 Sep; 29 Suppl 3():C15-25. PubMed ID: 21896348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.
    Schembri S; Morant S; Winter JH; MacDonald TM
    Thorax; 2009 Jul; 64(7):567-72. PubMed ID: 19321465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae.
    O'Brien KL; Nohynek H;
    Pediatr Infect Dis J; 2003 Feb; 22(2):e1-11. PubMed ID: 12586987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.